X-116172389-C-G
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_000686.5(AGTR2):āc.109C>Gā(p.Gln37Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000612 in 1,209,500 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 15 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_000686.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
AGTR2 | NM_000686.5 | c.109C>G | p.Gln37Glu | missense_variant | 3/3 | ENST00000371906.5 | NP_000677.2 | |
AGTR2 | NM_001385624.1 | c.109C>G | p.Gln37Glu | missense_variant | 2/2 | NP_001372553.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
AGTR2 | ENST00000371906.5 | c.109C>G | p.Gln37Glu | missense_variant | 3/3 | 1 | NM_000686.5 | ENSP00000360973 | P1 | |
AGTR2 | ENST00000681852.1 | c.109C>G | p.Gln37Glu | missense_variant | 2/2 | ENSP00000505750 | P1 | |||
AGTR2 | ENST00000680409.1 | n.577C>G | non_coding_transcript_exon_variant | 1/1 |
Frequencies
GnomAD3 genomes AF: 0.0000179 AC: 2AN: 111841Hom.: 0 Cov.: 23 AF XY: 0.00 AC XY: 0AN XY: 34041
GnomAD3 exomes AF: 0.0000491 AC: 9AN: 183130Hom.: 0 AF XY: 0.0000148 AC XY: 1AN XY: 67700
GnomAD4 exome AF: 0.0000656 AC: 72AN: 1097659Hom.: 0 Cov.: 31 AF XY: 0.0000413 AC XY: 15AN XY: 363173
GnomAD4 genome AF: 0.0000179 AC: 2AN: 111841Hom.: 0 Cov.: 23 AF XY: 0.00 AC XY: 0AN XY: 34041
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 26, 2022 | The c.109C>G (p.Q37E) alteration is located in exon 3 (coding exon 1) of the AGTR2 gene. This alteration results from a C to G substitution at nucleotide position 109, causing the glutamine (Q) at amino acid position 37 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at